"MURDER DOCTORS," SAY AIDS EXTREMISTS

19 June 1994

The extremist AIDS pressure group Gays Against Genocide has embarked upon a poster campaign in London, UK, urging patients with HIV infection to murder their doctors if they prescribe them Wellcome's Retrovir (zidovudine). The group has conducted a long campaign against the drug, saying that it is too toxic.

The posters mention leading AIDS specialists by name and call on patients to "kill your doctors before they kill you." Also singled out for harassment by GAG is the Terence Higgins Trust, a London-based not-for-profit organization which supports people affected by HIV and AIDS and provides educational information on the disease and related issues.

The two key members of GAG have reportedly been jailed for breaking an injunction preventing them from demonstrating and harassing people outside the THT offices. "We deplore what they are doing," said a THT spokesperson.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight